knowledge -WSS

knowledge

author：leisure time 2025-10-03 01:03:41 - browse：35

Venture firms backing health tech startups are telegraphing cautious optimism for 2024, advising startups to expect smaller and fewer checks as well as possible market consolidation but not to abandon hope just yet as investments stabilize following a sharp drop-off.

As customers — often health systems, payers, or employers — and backers plot how they’ll invest shrinking budgets, they’re increasingly savvy about metrics, investors told STAT. They’re also less interested in rapid growth, and more keen on startups that can demonstrate savings and efficiency.

That’s a sharp contrast from the unrestrained health tech investments that peaked in 2021, fueled by a pandemic-era frenzy for virtual appointments, mental health care and app-based therapies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Childhood vaccination ad campaign launches in the U.K.

WSS

Medicare isn't yet testing food as medicine

Woman gored by Bison at Yellowstone

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

Doctor of U.S. President Joe Biden says he is fit for duty

Study fuels hope CAR

There should be a 'Moonshot' or 'Warp Speed' for rare diseases

focus

knowledge

leisure time

The high cost of giving birth even with insurance

Doctor of U.S. President Joe Biden says he is fit for duty

In Memoriam: Notable people who died in 2023

Study fuels hope CAR

The cancer drug shortage isn’t new — and neither are the solutions

Virtual repurposing can help discover new uses for existing drugs

United colonoscopy coverage change 'may cost lives,' doctors say

Readout Newsletter: Beam, Prozac, "TechBio" and more

The cancer drug shortage isn’t new — and neither are the solutions

Readout Newsletter: GSK, Viking Therapeutics, mifepristone news

hotspot

Ohio train derailment: Experts on toxic chemical risks

Pfizer is about to make a big push in cancer. Will investors listen?

Who gets to use the title 'doctor'?

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

Mike Pence clashes with Tucker Carlson in Iowa

Laying a path for careers in science

knowledge

Wikipedia

hotspot

entertainment